HeartBeam receives Nasdaq minimum bid price deficiency notice
HeartBeam received a deficiency notice from Nasdaq on June 30, 2026, stating that the closing bid price of its common stock fell below the $1.00 per share minimum required for continued listing on The Nasdaq Capital Market. The company has until December 28, 2026, to regain compliance by achieving a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days. If the company fails to regain compliance within the 180-calendar-day cure period, it may qualify for a second 180-calendar-day compliance period, provided it meets other Nasdaq listing standards.
Key facts
- Deficiency notice received June 30, 2026
- Minimum bid price requirement: $1.00 per share under Nasdaq Listing Rule 5550(a)(2)
- 180-calendar-day compliance period until December 28, 2026
- Company must achieve $1.00 closing bid price for minimum of ten consecutive business days
- Second 180-calendar-day compliance period may be available if other listing standards are met
- No immediate effect on current listing status
Why it matters
HeartBeam has approximately six months to restore its stock price above the Nasdaq minimum bid threshold or face potential delisting from The Nasdaq Capital Market.
Share
Derived from 8-K filed 2026-07-02. Not investment advice. View the source filing on SEC.gov →